Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)

    Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically ESR.
    Favorite
    When to Use
    Pearls/Pitfalls
    Why Use

    Patients with confirmed rheumatoid arthritis.

    • The DAS Scores indicate how active a patient’s rheumatoid arthritis (RA) is currently, and can be trended over time.
    • They were initially developed for comparing clinical trial results of RA drugs, but are now used as overall markers of disease activity.
    • Recently a “treat to target” approach has been recommended: that a DAS score be frequently calculated until a patient’s score suggests disease remission, or to a particular ESR or CRP level.
    • The DAS scores were simplified, previously using 44 joints for assessment, and now instead use 28.

    Points to keep in mind:

    • There is some degree of inter-rater variability in assessing the DAS scores, as different raters may classify a joint as swollen or tender to different degrees.
    • The feet are not assessed in the DAS28 scores, since foot joint pains may be unrelated to RA activity (since we walk on our feet). Foot assessment, however, should still be considered in the patient’s broader gestalt, and foot complaints should obviously be considered and managed appropriately in RA patients.

    Recently a “treat to target” approach has been recommended: that a DAS score be calculated at frequent intervals while therapies are being given, until a patient’s score suggests disease remission, or to a particular ESR or CRP level.

    joints
    joints
    mm/hr

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Management

    The EULAR Response Criteria allows clinicians to categorize the effectiveness of a particular therapy. Please see the table below:

    Improvement in DAS28 score
    >1.2 0.6–1.2 ≤0.6
    Current DAS28 score ≤3.2 Good Moderate None
    3.2–5.1 Moderate Moderate None
    >5.1 Moderate None None

    Formula

    DAS28-ESR= (0.56*√(Tender Joint Count)+0.28*√(Swollen Joint Count)+0.7*ln(ESR)+0.014*(global health))

    Facts & Figures

    Score interpretation:

    DAS28 Score Range Disease Severity
    < 2.6 Remission
    ≥ 2.6 - < 3.2 Low
    ≥ 3.2 - ≤ 5.1 Moderate
    > 5.1 High

    Literature

    Dr. Désirée van der Heijde

    About the Creator

    Désirée van der Heijde, MD, is a professor of rheumatology at Leiden University Medical Center, the Netherlands and is affiliated with Diakonhjemmet Hospital in Oslo, Norway. She founded the Assessment in SpondyloArthritis international Society (ASAS) in 1995. Dr. van der Heijde is a principal investigator for clinical trials focused on rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

    To view Dr. Désirée van der Heijde's publications, visit PubMed